Assessing criminal justice involvement as an indicator of human immunodeficiency virus risk among women in methadone treatment by Epperson, Matthew W. et al.
Journal of Substance Abuse Treatment 38 (2010) 375–383Regular article
Assessing criminal justice involvement as an indicator of human
immunodeficiency virus risk among women in methadone treatment
Matthew W. Epperson, (Ph.D., M.S.W.)a,⁎, Maria R. Khan, (Ph.D.)b,
Daniel P. Miller, (Ph.D.)c, Brian E. Perron, (Ph.D.)d,
Nabila El-Bassel, (D.S.W.)e, Louisa Gilbert, (Ph.D.)e
aCenter for Behavioral Health Services and Criminal Justice Research, Rutgers University, New Brunswick, NJ 08901, USA
bSchool of Public Health, University of Maryland, College Park, MD 20742, USA
cSchool of Social Work, Boston University, Boston, MA, USA 02215
dSchool of Social Work, University of Michigan, Ann Arbor, MI 48109, USA
eSocial Intervention Group, Columbia University School of Social Work, New York, NY 10027, USA
Received 1 October 2009; received in revised form 26 February 2010; accepted 2 March 2010Abstract
This study examines the relationship between criminal justice involvement and high-risk sexual partnerships among a random sample of
416 women in methadone treatment in New York City. Logistic regression models were used to estimate the associations between recent
criminal justice involvement (arrest or incarceration in the past 6 months) and recent high-risk partnerships (multiple sex partners, sex
trading, or sex with a risky partner in the past 6 months) when adjusting for sociodemographic factors and recent regular drug use. Women
with recent criminal justice involvement demonstrated higher odds of engaging in high-risk sex partnerships. Although regular drug use was
a significant confounder of several of these relationships, recent arrest or incarceration remained significantly associated with multiple sex
partnerships, sex with a risky partner, and engaging in unprotected sex and a high-risk partnership even after controlling for regular drug use
and other social stressors. This study highlights the vulnerability of drug-involved women offenders to human immunodeficiency virus (HIV)
risk and points to the need for investigation into the role of arrest and incarceration as factors that may contribute to HIV infection. © 2010
Elsevier Inc. All rights reserved.Keywords: Criminal justice involvement; HIV risk; Methadone treatment1. Introduction
Addressing the burden of human immunodeficiency virus
(HIV) faced by women in the criminal justice system is an
important public health task. Women offenders display rates
of HIV that are three to five times that of the general
population of women (Belenko, Langley, Crimmins, &
Chaple, 2004; Maruschak, 2005). For over 15 years, the
prevalence of HIV among incarcerated women has been
even higher than among incarcerated men. In U.S. prisons⁎ Corresponding author. Center for Behavioral Health Services and
Criminal Justice Research, Rutgers University, 176 Ryders Lane, New
Brunswick, NJ, USA 08901. Tel.: +1 201 234 9357; fax: +1 732 932 1233.
E-mail address: mwepperson@gmail.com (M.W. Epperson).
0740-5472/10/$ – see front matter © 2010 Elsevier Inc. All rights reserved.
doi:10.1016/j.jsat.2010.03.004and jails, the highest rates of HIV are found among African
American (3.0%) and Hispanic (2.9%) women (Maruschak,
2004)—rates that are considerably greater than the estimated
HIV prevalence among African American (0.06%) and
Hispanic (0.02%) women in the general U.S. population
(CDC, 2008). For some female offender populations, the
levels are staggering; studies in the New York City area
document HIV rates of 18% among sampled female jail
inmates and 17% of sampled women on probation or parole
(Belenko et al., 2004; NYCDOH, 1999). Women are also the
fastest-growing segment of the U.S. criminal justice
population, and 1 in 89 women are currently under some
form of correctional control (Frost, Greene, & Pranis, 2006;
Pew, 2009). Despite these trends, there has been limited
research on drivers of HIV risk among women offenders, and
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specifically to target the complex needs of justice-involved
women (El-Bassel, Ivanoff, Schilling, Borne, & Gilbert,
1997; Mullings, Marquart, Carr, & Hartley, 2004; Staton-
Tindall et al., 2007). Research that examines factors that
influence HIV risk among women offenders to inform HIV
prevention interventions is clearly warranted.
The underlying causes for disproportionate HIV levels
among women in the criminal justice system are not entirely
clear. There appears to be a strong link between criminal
justice involvement andHIV-related sexual risk behaviors for
women; past studies have found that women with incarcer-
ation histories are significantly more likely than nonincar-
cerated women to exchange sex for money or drugs, to have
multiple and concurrent sexual partnerships, and to have been
the victim of forced sex (Hammett, Harmon, & Rhodes,
2002; Khan, Miller et al., 2008; Khan,Wohl et al., 2008; Kim
et al., 2002). Some have argued that criminal justice
involvement itself may contribute to HIV risk by exacerbat-
ing the instability of social networks, economic vulnerability,
and stigma, thus increasing the likelihood of HIV and other
health risk behaviors (Blankenship, Smoyer, Bray, &
Mattocks, 2005; Browning, Miller, & Lisa, 2001; Wheelock
& Uggen, 2005). In addition, arrest or incarceration is a
disruptive life event that destabilizes intimate partnerships,
which are protective against sexual risk behaviors such as
multiple and concurrent partnerships (Browning et al., 2001;
Comfort, Grinstead, McCartney, Bourgois, & Knight, 2005;
Rindfuss & Stephen, 1990). During an incarceration, the
prisoner's partner may seek additional sexual partners to fill
emotional or financial needs (Browning et al., 2001).
Absence of a partner, with freedom from restrictions on
sexual behavior, may lead released inmates to new and
multiple sexual partnerships (MacGowan et al., 2003).
One of the most common explanations for the link
between criminal justice involvement and HIV risk and
prevalence among women is the role of drug use (Altice et
al., 2005; El-Bassel et al., 1995; Epperson et al., 2009;
Grella, Annon, & Anglin, 2000). Over the past two decades,
changes in sentencing laws related to illicit drug use have
spurred a dramatic increase of drug-involved women in the
U.S. criminal justice system (Mauer & Kins, 2007). Most
women offenders are arrested for lower level charges
including drug violations and offenses associated with
substance abuse, such as shoplifting and prostitution
(Greenfeld & Snell, 2000). Nearly half of women confined
in local jails report committing their last offense under the
influence of alcohol or drugs (Karberg & James, 2005).
Concurrently, growing evidence suggests that substance
abuse is perceived by women as increasing sexual drive and
is likely to impair judgment and negotiation skills resulting
in an increased risk for having unwanted sex, sex with
multiple concurrent partners, and not using protection during
sex (Castillo Mezzich et al., 1997; El-Bassel et al., 1998;
Sterk, 1999, 2002). Given the high degree of overlap
between drug use and criminal justice involvement amongwomen, it is difficult to disentangle each factor's potential
role in contributing to HIV risk.
In addition to drug use, women in the criminal justice
system face many social hardships and psychological
distress, factors that may drive the association between
criminal justice involvement and HIV. HIV risk factors that
are overrepresented among women offenders include mental
illness (Blank & Eisenberg, 2007; Greenfeld & Snell, 2000),
histories of physical and sexual victimization (Belenko, Lin,
O'Connor, Sung, & Lynch, 2005; Harlow, 1999), and
homelessness (Greenfeld & Snell, 2000; Somlai, Kelly,
Wagstaff, & Whitson, 1998). Women of color are particu-
larly susceptible, facing increased risk for both criminal
justice involvement and HIV infection (Blankenship et al.,
2005). Because women in the criminal justice system
experience high vulnerability to these stressors, any study
on HIV risk among women offenders should carefully
address the potential confounding effect of these factors.
Such studies are difficult to conduct because there are limited
data sources that include good measurement of HIV risk,
criminal justice involvement, as well as social stressors, drug
use, and psychological distress.
The purpose of this study is to examine the associations
between criminal justice involvement and high-risk sexual
partnerships among women in drug treatment in New York
City while controlling for background factors that may
confound the association between criminal justice involve-
ment and HIV risk. We use data from baseline interviews
of a prospective study whose primary aim was to assess
social and psychological determinants of HIV infection
among women enrolled in methadone maintenance treat-
ment programs. By studying a sample of women with
similar drug dependence histories, for whom we also have
thorough measures on recent drug use, social hardship, and
psychological distress, this article serves to examine the
relationship between criminal justice involvement and
sexual HIV risk for drug-involved women while controlling
for an array of potential confounding factors. This study
responds to a pressing need to understand factors that drive
high levels of HIV among women offenders and thus will
improve our understanding of how to best plan effective
HIV prevention interventions for this vulnerable and
understudied population.2. Materials and methods
2.1. Participants and procedures
Data for this study come from a larger epidemiologic
study designed to examine determinants of HIV risk among
drug-involved women. A methadone-maintained sample was
chosen for several reasons, including this group's relative
stability compared with other drug-using populations as well
as its continued vulnerability to drug use, sexual risk
behaviors, and criminal involvement (Gilbert, El-Bassel,
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Kelly, & Forman, 2005). Using a random number generator
in SPSS, 750 women were randomly selected from a total
population of approximately 1,700 women enrolled in 14
methadone maintenance treatment programs in New York
City. About three fourths (n = 559) agreed to participate in a
screening interview. Of these 559 women, 427 met eligibility
criteria, which included (a) being female between the ages of
18 and 55 years, (b) being enrolled in methadone treatment
for at least 3 months, and (c) during the past year, having had
a sexual relationship with someone described as a boyfriend,
girlfriend, spouse, regular sexual partner, or father of her
children. Approximately 97% of women who were eligible
(n = 416) participated in a 90-minute structured interview for
this study.
Data were collected between 1998 and 2000 by female
research assistants with at least a bachelor's degree who
completed a 5-day training that included human subjects
issues, interviewing techniques, modeling, and role-playing
interview practice. To improve accuracy of self-reported
sexual behaviors, we used the timeline follow-back
method, which incorporates the use of a calendar, recall-
enhancing techniques, and visual cues to facilitate the
recall of sexual behaviors (Copersino, Meade, Bigelow, &
Brooner, 2010). Participants gave informed consent to
participate in the study and were compensated $5 for the
screening interview and $25 for participating in the
baseline interview. The institutional review boards of
Columbia University and the participating methadone
treatment programs approved the study protocol. A
detailed study description has been detailed in previous
work (El-Bassel, Gilbert, Wu, Go, & Hill, 2005; Wu, El-
Bassel, Gilbert, & Morse, 2006).
2.2. Measurement
2.2.1. Outcomes: High-risk sexual partnerships
We measured dichotomous indicators of HIV risk-
related sexual partnerships in the past 6 months, including
(a) multiple (two or more) sexual partnerships; (b) sex
trading, defined as exchanging sex for drugs or money; (c)
sex with a risky partner, defined as a partner with known or
suspected HIV infection or who was a recent injection drug
user; and (d) unprotected sex, defined as having at least one
unprotected vaginal or anal sex act. To further specify the
level of HIV risk involved in unprotected sex, we
constructed the outcome of high-risk partnership and
unprotected sex, defined as having both unprotected sex
and at least one of the following (all in the past 6 months):
multiple sex partnerships, sex trading, and/or sex with a
risky partner.
2.2.2. Exposure: recent criminal justice involvement
Was defined as having been arrested (apprehended by the
police and charged with a crime) or incarcerated (spent one
or more nights in custody) in the past 6 months.2.2.3. Sociodemographics
Self-reported sociodemographic data included participant
age, race/ethnicity, monthly income, marital status, years of
education, employment history, length of time in methadone
treatment, and history of homelessness. Participants also
self-reported their HIV infection status and whether they had
been diagnosed with a sexually transmitted infection (STI) in
the past 6 months. The Childhood Sexual Abuse Interview
was used to ascertain whether the participant had a history of
childhood sexual victimization (Sgroi, 1982).
2.2.4. Drug use
Lifetime and past 6-month use of illicit drugs was
assessed using the Drug Use and Risk Behavior Question-
naire (El-Bassel, Gilbert, Schilling, & Wada, 2000). This
instrument asks whether the participant had ever used a
specific drug and, if so, how often they used it in the past 6
months. For the purpose of this study, six drug use groupings
were defined: (a) heroin, (b) stimulants (including amphet-
amine, methamphetamine, and powder cocaine), (c) crack
(or freebased) cocaine, (d) marijuana, (e) prescription drugs
used without a prescription (including analgesics, tranquili-
zers, and sedatives), and (f) injection drug use of any kind.
Regular use was defined for each of the six drug groupings
as using the drug once a week or more frequently in the past
6 months.
2.2.5. Psychological distress
Psychological distress was measured using the Brief
Symptom Inventory (BSI; Derogatis, 1993), which assesses
severity of 53 psychological distress symptoms over the
prior 7 days (α = .96). We used the global severity index of
the BSI, which is calculated by averaging all completed
responses, with a possible range of 0–5 (higher scores
indicating higher levels of psychological distress).
2.3. Data analysis
Descriptive frequencies and/or means were calculated for
sociodemographic and behavioral variables. Past 6-month
regular drug use and HIV risk variables were assessed and
stratified by whether the participant had been arrested or
incarcerated in the past 6 months. Differences in regular drug
use and HIV risk variables between those with and without
recent arrest or incarceration were tested using chi-square
tests of independence.
Logistic regression was used to estimate unadjusted and
adjusted odds ratios (ORs) and 95% confidence intervals
(CIs) for associations between past 6-month criminal justice
involvement and each past 6-month high-risk sex partner-
ship. Adjusted analyses were conducted in two phases. In the
first adjusted model, we controlled for the following
sociodemographic variables: race/ethnicity, age, education,
income, marital status, recent homelessness, recent unem-
ployment, time in methadone treatment, current infection
with HIV or another STI, history of sexual abuse,
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severity index), and whether the participant had any same-
sex partnerships in the past 6 months. Because we expected
drug use to exert the greatest confounding effects, we
estimated a second adjusted model that controlled for the
previous sociodemographic variables plus past 6-month
regular use of each of the following: heroin, stimulants, crack
cocaine, marijuana, prescription drugs used without a
prescription, and any injection drug.3. Results
3.1. Sample characteristics
3.1.1. Sociodemographics
The mean age among women was nearly 40 years
(Table 1). Approximately half (48%) identified as Hispanic/
Latina, 31% African American, 17% White, and the
remaining 4% were of Asian or other racial/ethnic back-
grounds. The average educational attainment was approxi-
mately 11 years. Women reported low average monthly
income ($845) and employment in the past 6 months (21%),
and greater than half of the sample had ever been homeless
(53%). Sex with a female partner in the past 6 months was
somewhat rare (n = 37, 9%), and of these women, more than
half (n = 25) also reported having sex with male partners.
More than 90% of the sample (n = 375) reported ever being
tested for HIV, and 312 of these women (83%) reportedable 1
haracteristics of the study sample: women aged 22 to 55 years enrolled in
ethadone maintenance treatment programs, New York City (N = 416)
ge, M (SD) 39.8 (6.7)
ace/Ethnicity
Hispanic/Latina 199 (48%)
Black/African American 128 (31%)
White 70 (17%)
Asian/Other 19 (4%)
ducation (years), M (SD) 11.0 (2.5)
onthly income (dollars), M (SD) 845 (798)
urrently married 82 (20%)
mployed in the past 6 months 88 (21%)
elf-reported HIV infection 76 (18%)
elf-reported STI infection: past 6 months 50 (12%)
ears on methadone, M (SD) 9.2 (7.2)
SI—Global severity index, M (SD) 0.84 (0.71)
istory of sexual abuse 230 (55%)
istory of homelessness 220 (53%)
ifetime drug use history
Heroin 413 (99%)
Stimulants (including amphetamine and powder cocaine) 370 (89%)
Crack or freebased cocaine 283 (68%)
Marijuana 362 (87%)
Drugs without a prescription
(including analgesics, tranquilizers, and sedatives)
246 (59%)
Injected any type of drug 276 (66%)
riminal justice involvement
Ever arrested or incarcerated 294 (71%)

















being tested for HIV two or more times in their lifetime.
Approximately 18% of the sample (n = 76) reported known
HIV infection status.
3.1.2. Sexual abuse history and psychological distress
Greater than half of the women in this sample reported a
history of sexual abuse (55%). The average score on the BSI
global severity index was 0.84 (range = 0–3.7, SD = 0.71).
This value is comparable to those found among other drug-
involved female populations (El-Bassel et al., 1997), but it is
substantially higher than the estimated average of 0.37 for
the general female population (Derogatis, 1993).
3.1.3. Lifetime drug use history
Nearly all of the women in this study (n = 413, 99%)
reported heroin use in their lifetime; the three women who
did not report lifetime heroin use reported lifetime use of
other opiates. Other commonly used substances were
stimulants (89% lifetime use), marijuana (87%), and crack
or freebased cocaine (68%). About two thirds (66%) of the
sample reported an injection drug use history, and 59% had
used prescription drugs without a prescription.
3.1.4. Criminal justice involvement
Incarceration and arrest history were commonly reported
(Table 1). Seventy-one percent reported either being arrested
or incarcerated in their lifetime, and 11% (n = 46) had been
arrested or incarcerated in the past 6 months. For those
women incarcerated in the past 6 months, the average length
of incarceration was approximately 4 days.
3.2. Past 6-month regular drug use by past 6-month arrest
or incarceration
Women who had been arrested or incarcerated in the past
6 months demonstrated significantly higher levels of several
types of regular drug use, including crack cocaine (35% vs.
11%; p b .001), marijuana (24% vs. 8%; p b .001), drugs
used without a prescription (20% vs. 6%; p b .001), and
injecting any type of drug (22% vs. 11%; p b .05). Past 6-
month regular heroin or stimulant use did not differ
significantly between women who had or had not been
recently arrested or incarcerated (Table 2).
3.3. Past 6-month HIV risk indicators by past 6-month
arrest or incarceration
Women who had been recently arrested or incarcerated
reported higher levels of three high-risk sex partnerships
compared to women with no recent criminal justice
involvement, including multiple sex partners (30.5% vs.
11%; p b .001), sex trading (28% vs. 9%; p b .001), and
having a risky sex partner (52% vs. 27%; p b .001).
Proportions of women having unprotected sex were
comparable between women with (54%) and without
(53%) recent criminal justice involvement. Self-reported
Table 2
Past 6-month regular drug use and HIV risk indicators by arrest or incarceration in the past 6 months among women aged 22 to 55 years enrolled in methadone














χ2 (df = 1n % n % n %
Past 6-month regular drug use a
Heroin 82 20 70 19 12 26 1.33
Stimulants (including amphetamine and powder cocaine 26 6 23 6 3 6 .01
Crack cocaine 55 13 39 11 16 35 20.96 ⁎⁎⁎
Marijuana 41 10 30 8 11 24 11.50 ⁎⁎⁎
Drugs without a prescription (including analgesics,
tranquilizers, sedatives)
30 7 21 6 9 20 11.80 ⁎⁎⁎
Injected any type of drug 52 12.5 42 11 10 22 4.04 ⁎
Past 6-month high-risk partnerships
Two or more sex partners 54 13 40 11 14 30.5 13.95 ⁎⁎⁎
Sex trading 47 11 34 9 13 28 14.85 ⁎⁎⁎
Risky sex partner 125 30 101 27 24 52 12.05 ⁎⁎⁎
Any unprotected sex 221 53 196 53 25 54 .03
HIV/STI status
Self-reported STI in past 6 months 50 12 41 11 9 20 2.78
Self-reported HIV infection 76 18 62 17 14 30.5 5.13 ⁎
a Regular drug use is defined as use of each drug at least once per week in the past 6 months.
⁎ p b .05.
⁎⁎⁎ p b .001.
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arrested or incarcerated (30.5%) than among women with
no recent arrest or incarceration (17%; p b .05).
3.4. Recent criminal justice involvement and high-risk
sexual partnerships
3.4.1. Multiple sex partnerships
Women who were arrested or incarcerated in the past 6
months had more than three times the odds of having two or
more sex partnerships in the past 6 months as women
without recent criminal justice involvement (unadjusted
OR = 3.61, 95% CI = 1.78–7.33). Adjusting for socio-
demographic and other background characteristics changed
the estimate minimally. After additional adjustment for
regular drug use, the estimate weakened slightly but
remained significant (adjusted OR [AOR] = 3.02, 95%
CI = 1.23–7.43). Regular crack use, which was associated
with criminal justice involvement, was also strongly
associated with multiple partnerships (AOR = 4.25, 95%
CI = 1.89–9.58; Table 3).
3.4.2. Sex trading
Recent criminal justice involvement was strongly
associated with exchanging sex for money or drugs in
the past 6 months (unadjusted OR = 3.89, 95% CI =
1.87–8.10). After adjustment for respondent sociodemo-
graphic and other background factors, the OR was
reduced to 3.02 (95% CI = 1.28–7.13). The decreased
estimate was primarily due to adjustment for recent)
homelessness and psychological distress. Each of these
variables was associated with recent criminal justice
involvement, and the multivariable analysis indicated
that recent homelessness and psychological distress were
strongly associated with sex trade in the past 6 months
(homelessness: AOR = 2.71, 95% CI = 1.09–6.72; BSI/
GSI score: AOR = 2.58, 95% CI = 1.69–3.96). When
further adjusting for regular drug use, an association
remained, but the estimate was no longer statistically
significant (AOR = 2.25, 95% CI = 0.86–5.88). Drug use
confounded the association between criminal justice
involvement and sex trading; women who were regular
crack users were more likely to have engaged in sex
trading in the past 6 months versus nonregular users of
crack (AOR = 6.17, 95% CI = 2.55–14.96).
3.4.3. Sex with a risky partner
Women who had been arrested or incarcerated in the past
6 months were significantly more likely to have had a recent
sex partner who was known or suspected to be HIV-positive
or a recent injection drug user than women with no recent
criminal justice involvement (unadjusted OR = 2.91, 95%
CI = 1.56–5.41). When adjusting for sociodemographic and
other background characteristics, the estimate changed
minimally (AOR = 2.64, 95% CI = 1.33–5.25). Adjustment
for recent regular drug use resulted in a slightly weaker
estimate that remained significant (AOR = 2.54, 95% CI =
1.20–5.36). Regular injection drug use was strongly
associated with having a risky sex partner (AOR = 2.52,
95% CI = 1.29–4.91).
able 3
Rs and 95% CIs for the associations between arrest or incarceration in the past 6 months and high-risk sexual partnerships in the past 6 months among women
ged 22 to 55 years enrolled in methadone maintenance treatment programs, New York City (N = 416)
rrest or incarceration
ast 6 months)







OR (95% CI) adjusted
for respondent background
characteristics a
OR (95% CI) adjusted for
background characteristics and
past 6-month regular drug use b
ultiple sex partnerships
No (n = 370; 89%) 40 11 Referent Referent Referent
Yes (n = 46; 11%) 14 30 3.61 (1.78–7.33) 3.40 (1.51–7.68) 3.02 (1.23–7.43)
ex trading
No 34 9 Referent Referent Referent
Yes 13 28 3.89 (1.87–8.10) 3.02 (1.28–7.13) 2.25 (.86–5.88)
isky sex partner c
No 101 27 Referent Referent Referent
Yes 24 52 2.91 (1.56–5.41) 2.64 (1.33–5.25) 2.54 (1.20–5.36)
igh-risk partnership and unprotected sex d
No 92 25 Referent Referent Referent
Yes 21 46 2.54 (1.36–4.75) 2.59 (1.29–5.20) 2.32 (1.06–5.08)
a Background characteristics include race (Black, White, Hispanic, Asian/Other), age more than 40 years, high school diploma or equivalent, income (ordinal
ategorical), currently married, homeless in the past 6 months, employed in the past 6 months, years on methadone, current infection with HIV or another STI,
sychological distress measured by BSI/Global Severity Index score, lifetime history of sexual abuse, and any same-sex partnerships in the past 6 months.
b We adjusted for regular use (defined as using once or more per week) of each of the following in the past 6 months: heroin, stimulants (including
mphetamine and powder cocaine), crack cocaine, marijuana, drugs without a prescription (including analgesics, tranquilizers, and sedatives), and any
jection drug.
c Risky sex partner is defined as a sex partner in the past 6 months who was known or suspected to be HIV-positive or a recent injection drug user.
d In the past 6 months, participant has engaged in unprotected sex and at least one of the following: multiple sex partnerships, sex trading, or risky
ex partner.














3.4.4. High-risk partnership and unprotected sex
In the unadjusted analyses, recent criminal justice
involvement was associated with having both unprotected
sex and at least one high-risk partnership (multiple sex
partners, sex trading, and/or sex with a risky partner; OR =
2.54, 95% CI = 1.36–4.75). Adjusting for sociodemo-
graphic and background characteristics had little effect on
the estimate, and in the fully adjusted model including
recent regular drug use, the association remained strong and
statistically significant (AOR = 2.32, 95% CI = 1.06–5.08).
Having both unprotected sex and a high-risk partnership
was significantly associated with both regular crack cocaine
use (AOR = 2.22, 95% CI = 1.08–4.54) and regular
injection drug use (AOR = 4.65, 95% CI = 1.82–11.91).4. Discussion
4.1. Interpretation of findings
This study highlights criminal justice involvement as a
significant correlate of high-risk sexual partnerships in a
sample of drug-involved women. The results are consistent
with previous research that has linked a woman's incarcer-
ation to HIV infection (Altice et al., 2005; Maruschak, 2004;
Rich et al., 1999). Unique aspects of this study are a focus on
low-intensity criminal justice involvement (arrest or short-
term incarceration) and adjustment for regular drug use,
social stressors, and psychological distress—HIV risk
factors that disproportionately affect women offenders. Ourtwo-stage adjusted analyses revealed that after controlling
for sociodemographic and background characteristics, crim-
inal justice involvement was strongly associated with each of
the four sexual risk outcomes. Further adjustment demon-
strated that regular drug use, particularly crack cocaine and
injection drug use, is a major confounder to the association
between criminal justice involvement and risky sexual
partnerships. However, even after adjusting for regular
drug use, three of the four high-risk sexual partnerships
remained significantly associated with recent arrest or short-
term incarceration. Low-intensity criminal justice involve-
ment may serve as a marker for HIV risk among drug-
involved women due to the cyclical relationship between
drug use, arrest, and incarceration. Moreover, the findings
suggest the possibility that criminal justice involvement may
have a unique impact upon sexual risk-taking beyond the
role of drug use and other stressors.
Women in this study who were recently arrested or briefly
incarcerated were more likely to engage in multiple sex
partnerships. Although adjustment for sociodemographics
and drug use attenuated this relationship, criminal justice
involvement remained strongly associated with multiple sex
partnerships in the fully adjusted model. The results are
consistent with previously found associations between
incarceration and multiple and concurrent partnerships
among women (Khan, Wohl et al., 2008). These findings
suggest that criminal justice involvement is associated with
having multiple sex partners independent of adverse
background factors and drug use, and one plausible
explanation for this finding is that criminal justice
381M.W. Epperson et al. / Journal of Substance Abuse Treatment 38 (2010) 375–383involvement may increase the likelihood of HIV infection
among drug-involved women by contributing to multiple
sexual partnerships. Prior literature has suggested that the
stress associated with criminal justice involvement, together
with its disruptive effect on stable partnerships, may lead
women offenders to engage in new and multiple partnerships
(Adimora & Schoenbach, 2005; Browning et al., 2001). The
mounting evidence of the strong association between
criminal justice involvement and multiple sex partnerships
points to the need for research that can establish temporal
sequencing to clarify the potential effect of involvement in
the criminal justice system on women's relationships and
health (Freudenberg, 2002).
Although criminal justice involvement was associated
with sex trading in the unadjusted model, this relationship
was not significant in the fully adjusted model, largely due
to the confounding effects of regular crack cocaine use.
This finding highlights the vulnerability of crack-using
women to both HIV risk behaviors and repeated involve-
ment with the criminal justice system (El-Bassel et al.,
1996; Logan & Leukefeld, 2000). The strong connection
between drug use and criminal justice involvement also
suggests that these two factors may work reciprocally and
in tandem to lead to instability and sexual risk-taking, such
as sex trading, among women.
Recent criminal justice involvement was highly correlat-
ed with having a risky sex partner. Past research on intimate
partnerships has demonstrated a strong connection between
personal and sexual partner incarceration and drug use
(Epperson, Khan, El-Bassel, Wu, & Gilbert, 2010). It is
plausible, then, that drug-involved women who have
recently been arrested or incarcerated are more likely to
have sexual partners with direct and indirect risks associated
with their own drug use. Moreover, even short-term criminal
justice involvement may expose women to justice-involved
sexual partners, who have high rates of HIV and injection
drug use, thus increasing the overall risk of their sexual
networks. Furthermore, the strong unadjusted and fully
adjusted associations between criminal justice involvement
and having both unprotected sex and a high-risk sex
partnership warrant concern. Considering that 30% of the
women in this study with recent criminal justice involvement
report being HIV-positive, the association between criminal
justice involvement and having both unprotected sex and a
high-risk partnership indicates a significant opportunity for
HIV transmission between drug-involved women offenders
and their sexual partners.
4.2. Study limitations
There are several important limitations to this study. This
study relies upon self-report data, without biological or case
record confirmation of HIV status or criminal justice
involvement. We were also unable to determine whether
the study sample was significantly different from those who
refused to participate, which may be a source of bias.Although the sample's relative homogeneity on drug abuse is
a unique strength for the study aims, the women in this study
are, on average, somewhat older than the general population
of women offenders, which may impact the generalizability
of the findings. Further research is needed to ascertain
whether criminal justice involvement is a unique indicator of
HIV risk among diverse samples of women. The study uses a
cross-sectional design and is therefore limited in its ability to
draw a causal connection between the exposure of criminal
justice involvement and HIV/STI risk. The findings provide
evidence that criminal justice involvement is associated with
high-risk sexual partnerships among drug-involved women.
However, it is important to recognize that the relationship is
likely embedded within a broader set of complex feedback
relationships. That is, drug-involved women may engage in
various high-risk behaviors, which could lead to increased
likelihood of arrest or incarceration. In addition, engaging in
some sexual risk behaviors, such as sex trading, is illegal and
may place women at higher risk of arrest. Because this study
did not ascertain reason for arrest, the association between
illegal sexual risk behaviors and criminal justice involve-
ment could not be tested. Longitudinal data that capture the
temporal ordering of criminal involvement, drug use, sexual
risk behaviors, and reason for arrest can help to uncover and
clarify these relationships. Lastly, there is a time lag between
collection of the data and dissemination of these findings;
issues impacting this study may have changed over time,
including support systems and HIV prevention efforts with
drug-involved women offenders, and these changes could
influence the multiple factors related to criminal justice
involvement for women.
4.3. Implications for HIV prevention
Despite these limitations, the findings from this study
offer several implications for HIV prevention. Drug-
involved women with recent criminal justice involvement
represent a group in great need of targeted HIV prevention
services, and these women could be recruited from both
drug treatment and criminal justice settings. Incarceration-
based HIV prevention efforts for women remain an
important task. However, engaging women offenders
outside of incarceration settings is difficult but necessary
because more than 80% of the female correctional
population is not presently incarcerated but situated in the
community (i.e., on probation or parole) where they
experience greater opportunities to engage in drug- and
sexual-related risk behaviors (Belenko et al., 2004;
Greenfield & Snell, 1999; Spaulding et al., 2002).
Probation and alternative to incarceration programs are
potential settings to recruit such women for HIV prevention
interventions (Belenko et al., 2004; Epperson et al., 2009).
These strategies can build on existing HIV risk reduction
efforts that focus primarily on incarcerated women to build
a prevention continuum that more accurately reflects the
breadth of the female criminal justice population. In
382 M.W. Epperson et al. / Journal of Substance Abuse Treatment 38 (2010) 375–383addition, women in drug treatment programs, such as
methadone treatment, who experience arrest or incarcera-
tion may face additional HIV risks and as such should be
identified and targeted for involvement in HIV risk
reduction programs.
Drug-involved women in the criminal justice system
display a unique set of personal and social hardships.
Mental health problems and drug abuse are highly
prevalent among women offenders, and these stressors
have been linked to sexual risk behaviors in previous
research (Baillargeon et al., 2003; Logan & Leukefeld,
2000; McCoy, Lai, Metsch, Messiah, & Zhao, 2004). The
overlapping risk factors of drug use, psychological distress,
and criminal justice involvement present a complex
challenge to addressing treatment and HIV prevention
needs for drug-involved women (Peugh & Belenko, 1999).
Such interventions would benefit by including a psycho-
social assessment and the capacity to link women to
appropriate mental health services. An appraisal of service
and support needs, such as housing and employment, may
help to reduce not only HIV risk but criminal recidivism as
well. In addition, considering the significant overlap
between drug use and HIV risk for women offenders,
access to drug treatment among offender populations must
be expanded and understood as a potential protective factor
against the spread of HIV (Semaan et al., 2002; Sorensen &
Copeland, 2000). Medical settings, particularly emergency
departments, could include HIV screening, testing, and
prevention efforts for women with drug involvement and
overlapping risk factors. Particularly relevant to this study
sample is the high risk of overdose after incarceration
among opiate users, which should be addressed in
prevention efforts with drug-involved women offenders
(Binswanger et al., 2007; Wakeman, Bowman, McKenzie,
Jeronimo, & Rich, 2009).
4.4. Conclusion
This study finds that despite the considerable impact of
drug abuse and other stressors on sexual HIV risk, criminal
justice involvement remains a significant correlate of high-
risk sexual partnerships among drug-involved women. An
increased focus on the health risks and needs of drug-
involved women in the criminal justice system is necessary to
advance the health of this underserved population. Continued
examination of criminal justice policy and practice as it
affects women is therefore not only a matter of public safety
but also an important component of public health.
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